CN1126492A - 腮腺炎病毒的重组抗原及其在疫苗中的用途 - Google Patents

腮腺炎病毒的重组抗原及其在疫苗中的用途 Download PDF

Info

Publication number
CN1126492A
CN1126492A CN94192620.6A CN94192620A CN1126492A CN 1126492 A CN1126492 A CN 1126492A CN 94192620 A CN94192620 A CN 94192620A CN 1126492 A CN1126492 A CN 1126492A
Authority
CN
China
Prior art keywords
protein
called
carrier
paper
zone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94192620.6A
Other languages
English (en)
Chinese (zh)
Inventor
亚历克斯·博伦
索菲·霍阿德
厄林·C·J·诺尔比
塔马斯·M·瓦桑伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of CN1126492A publication Critical patent/CN1126492A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN94192620.6A 1993-04-30 1994-04-26 腮腺炎病毒的重组抗原及其在疫苗中的用途 Pending CN1126492A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9308963.9 1993-04-30
GB939308963A GB9308963D0 (en) 1993-04-30 1993-04-30 Novel compounds

Publications (1)

Publication Number Publication Date
CN1126492A true CN1126492A (zh) 1996-07-10

Family

ID=10734747

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94192620.6A Pending CN1126492A (zh) 1993-04-30 1994-04-26 腮腺炎病毒的重组抗原及其在疫苗中的用途

Country Status (8)

Country Link
EP (1) EP0695358A1 (fr)
JP (1) JPH08512199A (fr)
KR (1) KR960702000A (fr)
CN (1) CN1126492A (fr)
AU (1) AU6964894A (fr)
CA (1) CA2161645A1 (fr)
GB (1) GB9308963D0 (fr)
WO (1) WO1994025600A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1843507B (zh) * 2006-02-14 2010-04-21 中国医学科学院医学生物学研究所 一种人用腮腺炎病毒组份疫苗及其制备方法和应用
CN106290862A (zh) * 2016-08-05 2017-01-04 北京市华信行生物科技有限公司 腮腺炎病毒hn抗原及其在检测抗腮腺炎病毒抗体中的用途

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100064A (en) * 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
CA2283536C (fr) * 1997-03-11 2009-09-01 Cambridge Genetics Limited Compositions et methodes d'elimination de cellules indesirables
AU7915398A (en) * 1997-05-23 1998-12-11 Schwiez. Serum-& Impfinstitut Bern An influenza enveloped dna vaccine
WO2000018929A2 (fr) * 1998-09-25 2000-04-06 Smithkline Beecham Biologicals S.A. Nouveaux composés
WO2021119497A1 (fr) * 2019-12-11 2021-06-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunogènes des virus des oreillons et de la rougeole et utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011534A1 (fr) * 1988-05-24 1989-11-30 Board Of Regents, The University Of Texas System Hemagglutinine-neuraminidase du virus des oreillons

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1843507B (zh) * 2006-02-14 2010-04-21 中国医学科学院医学生物学研究所 一种人用腮腺炎病毒组份疫苗及其制备方法和应用
CN106290862A (zh) * 2016-08-05 2017-01-04 北京市华信行生物科技有限公司 腮腺炎病毒hn抗原及其在检测抗腮腺炎病毒抗体中的用途
CN106290862B (zh) * 2016-08-05 2017-10-31 北京市华信行生物科技有限公司 腮腺炎病毒hn抗原及其在检测抗腮腺炎病毒抗体中的用途

Also Published As

Publication number Publication date
GB9308963D0 (en) 1993-06-16
JPH08512199A (ja) 1996-12-24
EP0695358A1 (fr) 1996-02-07
WO1994025600A1 (fr) 1994-11-10
CA2161645A1 (fr) 1994-11-10
KR960702000A (ko) 1996-03-28
AU6964894A (en) 1994-11-21

Similar Documents

Publication Publication Date Title
Taylor et al. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens
JP2023071901A (ja) キメラ分子およびその使用
JP3624911B2 (ja) 組換えアビポックスウイルス
CN111603557A (zh) 一种包膜替换型病毒载体疫苗及其构建方法
CN104471064B (zh) 副粘病毒及其用途
JPH05103667A (ja) シチメンチヨウの組換えヘルペスウイルスおよび該ウイルス由来の生菌ベクターワクチン
JP3939358B2 (ja) 組替え豚痘ウイルス
JP3824619B2 (ja) 麻疹ウイルス組換え体ポックスウイルスワクチン
JP4691495B2 (ja) コロナウイルススパイクｓ１融合蛋白及びその発現ベクター
EP3856240A1 (fr) Compositions et procédés de fabrication et d'utilisation de particules de type viral (vlp)
CN1126492A (zh) 腮腺炎病毒的重组抗原及其在疫苗中的用途
Lehman et al. Comparison of soluble and secreted forms of human parainfluenza virus type 3 glycoproteins expressed from mammalian and insect cells as subunit vaccines
Shehata et al. Development of a recombinant ELISA using yeast (Pichia pastoris)-expressed polypeptides for detection of antibodies against avian influenza A subtype H5
RU2734118C2 (ru) Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита
CN118165124B (zh) 一种重组猪干扰素λ1、猪干扰素γ和猪Fc的融合蛋白及其应用
KR100265393B1 (ko) 고양이 백혈병 바이러스 백신
CN118165125B (zh) 一种重组猪干扰素λ1、猪干扰素γ和猪SA的融合蛋白及其应用
JPH11507241A (ja) 組換え鶏痘ウイルスおよびその使用
CN1117150C (zh) 编码诊断相关的病毒衣壳抗原的eb病毒dna序列,通过聚合酶链反应产生的表达克隆和该重组抗原在诊断检测中的应用
US20250250304A1 (en) Recombinant newcastle disease virus expressing lassa virus gp or np, and uses thereof
Thomsen et al. Applications of insect cell gene expression in pharmaceutical research
Fodor et al. Nucleotide and deduced amino acid sequences of the glycoprotein gene of rabies virus vaccine strain Vnukovo-32
AU2017275663A1 (en) Modification of engineered influenza hemagglutinin polypeptides
CN115368468B (zh) 一种新型冠状病毒SARS-CoV-2突变体疫苗与应用
CA3112040C (fr) Compositions et procedes de fabrication et d'utilisation de particules de type viral (vlp)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication